Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Nivolumab
Bartholin Gland Transitional Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Basal Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Bladder Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Bladder Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Bladder Mixed Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Adnexal Spiradenoma/Cylindroma Of A Sweat Gland
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Malignant Spiradenoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Cervical Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Cervix Melanoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Oropharynx Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Colorectal Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Digital Papillary Eccrine Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Down Syndrome
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrium Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrial Undifferentiated Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrial Mixed Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrial Mucinous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrial Transitional Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Epstein-Barr Virus Infection
National Cancer Institute (NCI)P2CCC (53)
Showing 1701 to 1725 of 3,272 assets
PreviousPage 69 of 131Next